These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18005515)

  • 21. HIV testing and prophylaxis to prevent mother-to-child transmission in the United States.
    American Academy of Pediatrics Committee on Pediatric AIDS
    Pediatrics; 2008 Nov; 122(5):1127-34. PubMed ID: 18977995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The changing pattern of adherence to antiretroviral therapy assessed at two time points, 12 months apart, in a cohort of HIV-infected children.
    Giannattasio A; Albano F; Giacomet V; Guarino A
    Expert Opin Pharmacother; 2009 Dec; 10(17):2773-8. PubMed ID: 19929700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregnancy outcomes and antiretroviral treatment in a national cohort of pregnant women with HIV: overall rates and differences according to nationality.
    Floridia M; Tamburrini E; Bucceri A; Tibaldi C; Anzidei G; Guaraldi G; Meloni A; Guerra B; Ferrazzi E; Molinari A; Pinnetti C; Salerio B; Ravizza M;
    BJOG; 2007 Jul; 114(7):896-900. PubMed ID: 17501959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacoepidemiological approach to the predisposing factors for highly active antiretroviral therapy failure in an HIV-positive cohort from Cordoba City (Argentina) 1995-2005.
    Soria EA; Cadile II; Allende LR; Kremer LE
    Int J STD AIDS; 2008 May; 19(5):335-8. PubMed ID: 18482965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse effects of antiretrovirals in HIV-infected pregnant women.
    Zuk DM; Hughes CA; Foisy MM; Robinson JL; Singh AE; Houston S
    Ann Pharmacother; 2009 Jun; 43(6):1028-35. PubMed ID: 19491318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment.
    Roux P; Carrieri MP; Cohen J; Ravaux I; Poizot-Martin I; Dellamonica P; Spire B
    Clin Infect Dis; 2009 Nov; 49(9):1433-40. PubMed ID: 19807275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive clinical adherence interventions to enable antiretroviral therapy: a case report.
    Nicca D; Moody K; Elzi L; Spirig R
    J Assoc Nurses AIDS Care; 2007; 18(6):44-53. PubMed ID: 17991598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perioperative cesarean delivery morbidity among HIV-infected women under highly active antiretroviral treatment: a case-control study.
    Maiques V; Garcia-Tejedor A; Diago V; Molina JM; Borras D; Perales-Puchalt A; Perales A
    Eur J Obstet Gynecol Reprod Biol; 2010 Nov; 153(1):27-31. PubMed ID: 20675036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postpartum contraceptive preferences of HIV-infected women in the era of highly active antiretroviral therapy (HAART) and scheduled cesarean deliveries.
    Tuuli MG; Duong TH; Yost NP; Ellis J; Burke CV; Basanta-Henry PL; Lindsay M
    Contraception; 2011 Aug; 84(2):150-4. PubMed ID: 21757056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adherence to HAART.
    Proj Inf Perspect; 1997 Jul; (22):20-3. PubMed ID: 11364576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adherence to antiretroviral therapy among HIV-infected prison inmates (Spain).
    Soto Blanco JM; Pérez IR; March JC
    Int J STD AIDS; 2005 Feb; 16(2):133-8. PubMed ID: 15807941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy.
    Haeri S; Shauer M; Dale M; Leslie J; Baker AM; Saddlemire S; Boggess K
    Am J Obstet Gynecol; 2009 Sep; 201(3):315.e1-5. PubMed ID: 19733286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapy.
    Lima VD; Gill VS; Yip B; Hogg RS; Montaner JS; Harrigan PR
    J Infect Dis; 2008 Jul; 198(1):51-8. PubMed ID: 18498238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa.
    Hamers RL; Derdelinckx I; van Vugt M; Stevens W; Rinke de Wit TF; Schuurman R;
    Antivir Ther; 2008; 13(5):625-39. PubMed ID: 18771046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Difficulties to follow up exposed to antiretroviral therapy and non infected children born from HIV-infected mother after 2 years of age].
    Sarret C; Paillard C; Cormerais L; Demeocq F; Jacomet C
    Arch Pediatr; 2008 Mar; 15(3):326-7. PubMed ID: 18325748
    [No Abstract]   [Full Text] [Related]  

  • 38. Disease progression in HIV-1 infected children and adolescents--results of a German-Austrian cohort study.
    Funk MB; Buchholz B; Notheis G; Neubert J; Feiterna-Sperling C; Ganschow R; Simon T; Hornemann F; Peters AM; Rütschle H; Horneff G; Lechner E; Hanschmann KM; Wintergerst U;
    Eur J Med Res; 2008 Aug; 13(8):371-8. PubMed ID: 18952519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to Kourtis et al. 'Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis'.
    Townsend CL; Cortina-Borja M; Peckham CS; Tookey PA
    AIDS; 2007 Aug; 21(13):1831-2. PubMed ID: 17690590
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of depression in predicting antiretroviral adherence in Ugandan parents and their children initiating HAART in the MTCT-plus family treatment model: commentary on Jayne Byakika-Tusiime et al. 2009.
    Nakimuli-Mpungu E; Musisi S
    AIDS Behav; 2009 Oct; 13(5):969-72. PubMed ID: 19662522
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.